House Committee Widens Ranbaxy Probe

Law360, New York (September 19, 2008, 12:00 AM EDT) -- The U.S. House of Representatives Committee on Energy and Commerce has expanded its probe of Ranbaxy Laboratories, with lawmakers demanding to take a deeper look at the president's emergency program for AIDS relief, which may have been compromised by alleged manufacturing deficiences at two plants in India.

On Thursday, committee chairman Rep. John D. Dingell, D-Mich., revealed that other congressional members had joined the investigation into Ranbaxy, which came under fire earlier this week.

On Tuesday, the U.S. Food and Drug Administration barred more than 30...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.